Prevalence and clinical aspects of depression in Parkinson’s disease: a systematic review and meta‑analysis of 129 studies

Serotonergic and Dopaminergic Lesions Underlying Parkinsonian Neuropsychiatric Signs

(2021) Audrey Maillet et al.   MOVEMENT DISORDERS

Efficacy and safety of the 5‐Hydroxytryptophan on Depression and Apathy in Parkinson's disease: a preliminary finding

(2020) Mario Meloni et al.   EUROPEAN JOURNAL OF NEUROLOGY

Parkinson’s disease: etiopathogenesis and treatment

(2020) Joseph Jankovic et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Evaluating the Role of SNCA , LRRK2 , and GBA in Chinese Patients With Early‐Onset Parkinson's Disease

(2020) Yongping Chen et al.   MOVEMENT DISORDERS

Late onset depression: dopaminergic deficit and clinical features of prodromal Parkinson’s disease: a cross-sectional study

(2020) Hiba Kazmi et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

A randomized controlled double-blind study of rotigotine on neuropsychiatric symptoms in de novo PD

(2020) A. Castrioto et al.   npj Parkinsons Disease

Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review

(2019) Klaus Seppi et al.   MOVEMENT DISORDERS

Depression in neurodegenerative diseases: Common mechanisms and current treatment options

(2019) Ciaran P.C. Galts et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Bipolar disorder and depression in early adulthood and long‐term employment, income, and educational attainment: A nationwide cohort study of 2,390,127 individuals

(2019) Christian Hakulinen et al.   DEPRESSION AND ANXIETY

RoB 2: a revised tool for assessing risk of bias in randomised trials

(2019) Jonathan A C Sterne et al.   BMJ-British Medical Journal

Prevalence and clinical aspects of mild cognitive impairment in Parkinson's disease: A meta‐analysis

(2019) Chiara Baiano et al.   MOVEMENT DISORDERS

Assessment and Management of Neuropsychiatric Symptoms in Parkinson’s Disease

(2018) Christoph Mueller et al.   CNS DRUGS

Vascular risk factors and depression in Parkinson's disease

(2018) R. Ou et al.   EUROPEAN JOURNAL OF NEUROLOGY

α-Synuclein accumulation and GBA deficiency due to L444P GBA mutation contributes to MPTP-induced parkinsonism

(2018) Seung Pil Yun et al.   Molecular Neurodegeneration

Depression

(2018) Gin S Malhi et al.   LANCET

Non-motor features of Parkinson disease

(2017) Anthony H. V. Schapira et al.   NATURE REVIEWS NEUROSCIENCE

Gender differences in depression in representative national samples: Meta-analyses of diagnoses and symptoms.

(2017) Rachel H. Salk et al.   PSYCHOLOGICAL BULLETIN

Prevalence and risk factors for depression and anxiety in Chinese patients with Parkinson disease

(2017) Shi-Shuang Cui et al.   BMC Geriatrics

Survival and dementia inGBA-associated Parkinson's disease: The mutation matters

(2016) Roberto Cilia et al.   ANNALS OF NEUROLOGY

The prominent role of serotonergic degeneration in apathy, anxiety and depression inde novoParkinson’s disease

(2016) Audrey Maillet et al.   BRAIN

Parkinson's Disease with Fatigue: Clinical Characteristics and Potential Mechanisms Relevant to α-Synuclein Oligomer

(2016) Li-Jun Zuo et al.   Journal of Clinical Neurology

Detecting depression in Parkinson disease

(2016) Zahra Goodarzi et al.   NEUROLOGY

Depression and anxiety are co-morbid but dissociable in mild Parkinson's disease: A prospective longitudinal study of patterns and predictors

(2016) Natalie Wee et al.   PARKINSONISM & RELATED DISORDERS

Glucocerebrosidase activity in Parkinson’s disease with and withoutGBAmutations

(2015) Roy N. Alcalay et al.   BRAIN

Apathy in Parkinson's disease: clinical features, neural substrates, diagnosis, and treatment

(2015) Javier Pagonabarraga et al.   LANCET NEUROLOGY

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation

(2015) L. Shamseer et al.   BMJ-British Medical Journal

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation

(2015) L. Shamseer et al.   BMJ-British Medical Journal

Combined Rasagiline and Antidepressant Use in Parkinson Disease in the ADAGIO Study

(2015) Kara M. Smith et al.   JAMA Neurology

Differences in striatal dopamine transporter density between tremor dominant and non-tremor Parkinson’s disease

(2014) Valtteri Kaasinen et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Cognitive impairment and dementia in Parkinson's disease: Practical issues and management

(2014) Murat Emre et al.   MOVEMENT DISORDERS

Subthreshold depression and subjective cognitive complaints in Parkinson's disease

(2013) G. Santangelo et al.   EUROPEAN JOURNAL OF NEUROLOGY

Rivastigmine in apathetic but dementia and depression-free patients with Parkinson's disease: a double-blind, placebo-controlled, randomised clinical trial

(2013) D. Devos et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Depressive symptoms in Parkinson's disease are related to reduced [123I]FP-CIT binding in the caudate nucleus

(2013) C. Vriend et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a 123I-FP-CIT SPECT study

(2012) Daniela Di Giuda et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Cross-national epidemiology of DSM-IV major depressive episode

(2011) Evelyn Bromet et al.   BMC Medicine

Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation

(2010) S. Thobois et al.   BRAIN

Fatigue in Parkinson's disease is linked to striatal and limbic serotonergic dysfunction

(2010) N. Pavese et al.   BRAIN

The identification of Parkinson's disease subtypes using cluster analysis: A systematic review

(2010) Stephanie M. van Rooden et al.   MOVEMENT DISORDERS

The impact of treatment of depression on quality of life, disability and relapse in patients with Parkinson's disease

(2009) Matthew Menza et al.   MOVEMENT DISORDERS